科伦药业(002422.SZ)：前三季度净利润12.01亿元 同比减少51.41%

Core Viewpoint - Kelun Pharmaceutical (002422.SZ) reported a significant decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 13.277 billion yuan, representing a year-on-year decrease of 20.92% [1] - The net profit attributable to shareholders was 1.201 billion yuan, down 51.41% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 1.147 billion yuan, a decrease of 53.12% year-on-year [1] - Basic earnings per share were reported at 0.75 yuan [1]